Purchase this article with an account.
Kazuhiko Umazume, Yoshihiro Wakabayashi, Yoshihiko Usui, Hiroshi Goto; Outcome of vitrectomy for retinal hemangioma. Invest. Ophthalmol. Vis. Sci. 2019;60(9):3549.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Retinal hemangioma requires treatment by pars plana vitrectomy in the case of occurrence of serous retinal detachment, macular edema or secondary epiretinal membrane. We examined the clinical characteristics and postoperative results of patients with retinal hemangioma who underwent vitrectomy at our hospital.
Eighteen patients (18 eyes) diagnosed with retinal hemangioma and treated at Tokyo Medical University hospital between 2013 and 2018 were studied. The 18 patients comprised 5 males and 13 females, with mean age of 58.2±19.9 years. Type of hemangioma (hemangioblastoma, retinal vasoproliferative tumor; VPTR), preoperative fundus lesion (epiretinal membrane, serous retinal detachment, cystoid macular edema, vitreous hemorrhage), intraoperative procedure (cryotherapy, laser photocoagulation), pre- and post-operative visual acuity, and postoperative complications were analyzed.
For type of hemangioma, 2 patients had hemangioblastoma and 16 patients had VPTR. Preoperative examinations detected epiretinal membrane in 16 patients (88.9%), cystoid macular edema in 2 patients and vitreous hemorrhage in 1 patient. Together with vitrectomy, cryotherapy was conducted in 16 cases and laser photocoagulation in 13 cases. Activity of hemangioma was controlled in 17 eyes (94.4%) after treatment Visual acuity improved significantly at 3 months after surgery (p<0.01).
Vitrectomy combined with cryotherapy and retinal photocoagulation for retina hemangioma with intraocular complications improve visual function and control the activity of hemangioma.
This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.
This PDF is available to Subscribers Only